Methods Pediatric oncology patients (n=100) completed PROMIS Pediatric item banks for Anxiety v3.0, Depressive Symptoms v3.0, Peer Relationships v3.0, Mobility v3.0, Fatigue v3.0, and Sleep Disturbances v1.0, as well as Global Health v1.0 scale, Anger 9a v3.0 short form, and Pain Intensity item v1.0
The latest on the scene: retatrutide , a so-called "triple-agonist" that targets GLP-1, GIP, and glucagon receptors
Habener and his team were investigating the proglucagon gene, which is responsible for producing several important peptides, including GLP-1
Better data turns a hopeful guess into a decision you can adjust
Long-term safety and tolerability
[3] [4] The role of GIP receptor activation is not fully understood